Jane Street’s PhenomeX Inc. Common Stock CELL Stock Holding History

Jane Street’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-23,800	Closed	-$118K	–	10751
2022 Q2	$118K	Sell	23,800 -28,600	-55%	-$150K	﹤0.01%	8540
2022 Q1	$373K	Buy	52,400 +1,800	+4%	+$14.9K	﹤0.01%	8025
2021 Q4	$920K	Sell	50,600 -30,900	-38%	-$667K	﹤0.01%	6062
2021 Q3	$1.59M	Buy	81,500 +61,600	+310%	+$2.34M	﹤0.01%	4950
2021 Q2	$892K	Buy	19,900 +8,600	+76%	+$399K	﹤0.01%	6070
2021 Q1	$568K	Buy	+11,300	New	+$770K	﹤0.01%	6572

Jane Street's CELL Position: Q4 2023 in Review

Jane Street sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 181,371 shares — an estimated $181K sold.

Jane Street first reported a position in CELL in Q4 2020 and held it in 11 quarters. The position peaked at $1.35M in Q1 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

Jane Street reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Jane Street sold 181,371 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $181K.
Jane Street first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 11 quarters.
Jane Street's PhenomeX Inc. Common Stock position peaked at $1.35M in Q1 2021.
0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.